This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 126-DD:1 · Commission Established

126-DD:1 Commission Established. –

Copy link
I.

There is established a commission to review information and data related to drug overdose fatalities in New Hampshire. The members of the commission shall be as follows:

Copy link
(a)

One member of the senate, appointed by the president of the senate.

Copy link
(b)

Three members of the house of representatives, appointed by the speaker of the house of representatives.

Copy link
(c)

The attorney general, or designee.

Copy link
(d)

The chief medical examiner, or designee.

Copy link
(e)

The commissioner of the department of health and human services, or designee.

Copy link
(f)

The commissioner of the department of safety, or designee.

Copy link
(g)

The chairperson of the governor's commission on addiction, treatment, and prevention, or designee.

Copy link
(h)

A representative of the New Hampshire Association of Chiefs of Police, appointed by the association.

Copy link
(i)

A representative of the New Hampshire Association of Fire Chiefs, appointed by the association.

Copy link
(j)

A health official from a city health department, appointed by the governor.

Copy link
(k)

A victim/witness advocate, appointed by the attorney general.

Copy link
(l)

A representative of the New Hampshire Hospital Association, appointed by the association.

Copy link
(m)

A representative of the recovery community, appointed by the governor.

Copy link
(n)

A representative of the treatment community, appointed by the governor.

Copy link
(o)

A representative of the prevention community, appointed by the governor.

Copy link
(p)

A representative of New Futures, appointed by that organization.

Copy link
(q)

A representative from American Medical Response, appointed by that organization.

Copy link
(r)

A representative of the Drug Enforcement Administration, appointed by the administration.

Copy link
(s)

The governor's advisor on addiction and behavioral health.

Copy link
(t)

A suicide prevention specialist, appointed by NAMI-New Hampshire.

Copy link
(u)

A representative of the New Hampshire Medical Society, appointed by the society.

Copy link
II.

(a) Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.

Copy link
(b)

A member of the commission appointed under subparagraphs I(a)-(g) or (s) shall serve a term conterminous with their term in office. A member appointed under subparagraph I(h)-(r) or (t) shall serve a 6-year term, provided that initial appointments shall be for staggered terms of one to 6 years.

Copy link
(c)

Members of the commission shall sign confidentiality statements that prohibit any unauthorized dissemination of information except when disclosures may be necessary to enable the commission to carry out its duties under this subdivision. No material shall be used for reasons other than for which it was intended.

Copy link
III.

(a) The commission shall:

Copy link
(1)

Review trends and patterns of overdose-related fatalities in New Hampshire.

Copy link
(2)

Identify high-risk factors, current practices, and gaps in system responses.

Copy link
(3)

Recommend policies, practices, and services that will encourage collaboration and reduce overdose fatalities.

Copy link
(4)

Improve sources of data collection by developing a system to share information between agencies and offices that work with individuals struggling with addiction.

Copy link
(5)

Educate the public, policy makers, and funders about overdose-related fatalities and about strategies for intervention and effective prevention, treatment, and recovery.

Copy link
(6)

Review laws and programs enacted in other states, counties, or municipalities. (b)(1) Upon the request of the chairperson of the commission and as necessary to carry out the commission's duties, the chairperson shall be provided, within 5 days excluding weekends and holidays, with access to information and records regarding a drug overdose fatality that is being reviewed by the commission or regarding the person who overdosed on drugs. The commission may request the information and records from any of the following:

Copy link
(A)

A provider of medical, dental, or behavioral health care.

Copy link
(B)

Any state or a political subdivision of this state that might assist the commission in reviewing the fatality.

Copy link
(2)

A law enforcement agency, with the approval of the prosecuting attorney, may withhold from a review team investigative records that may interfere with a pending criminal investigation or prosecution.

Copy link
IV.

(a) The members of the commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the senate member. The first meeting of the commission shall be held within 45 days of the effective date of this section. Eleven members of the commission shall constitute a quorum.

Copy link
(b)

The department of health and human services shall provide administrative support to the commission.

Copy link
V.

The commission shall:

Copy link
(a)

Meet no fewer than 6 times per year to conduct reviews of overdose fatalities.

Copy link
(b)

Study the adequacy of statutes, rules, training, and services to determine what changes are needed to decrease the incidence of preventable overdose fatalities and, as appropriate, take steps to implement these changes.

Copy link
(c)

Educate the public regarding the incidence and causes of overdose fatalities and the public's role in preventing these deaths.

Copy link
(d)

Review all overdose fatalities except for fatalities of children under 18 years of age and fatalities related to women while pregnant or with one year of the end of pregnancy.

Copy link
(e)

Complete an annual statistical report on the incidence and causes of overdose fatalities in this state during the past fiscal year and submit a copy of this report, including its recommendations for proposed legislation and actions, to the governor, the senate president, and the speaker of the house of representatives. The commission shall submit the report on or before December 15 of each year commencing on December 15, 2021.

Copy link
VI.

The commission shall not:

Copy link
(a)

Call witnesses or take testimony from individuals who have been identified by the department of justice as potential witnesses in any criminal prosecution arising from an overdose death until the completion of such prosecution.

Copy link
(b)

Enforce any public health standard or criminal law or otherwise participate in any legal proceeding, unless a member of the team is involved in the investigation of the death or resulting prosecution and must participate in a legal proceeding in the course of performing his or her duties outside the team.

Copy link
VII.

(a) Proceedings, records, and opinions of the commission are confidential, not subject to RSA 91-A, and not subject to discovery, subpoena, or introduction into evidence in any civil or criminal proceeding. Nothing in this subparagraph shall be construed to limit or restrict the right to discover or use in any civil or criminal proceeding anything that is available from another source and entirely independent of the proceedings of the commission.

Copy link
(b)

Members of the commission shall not be questioned in any civil or criminal proceeding regarding information presented in or opinions formed as a result of a meeting of the team. Nothing in this subparagraph shall be construed to prevent a member of the commission from testifying to information obtained independently of the commission or which is public information.

Copy link
VIII.

(a) The commission shall maintain the confidentiality of all records pursuant to RSA 169-C:25, RSA 170-G:8-a, and all other related confidentiality laws.

Copy link
(b)

The information and records obtained and created in execution of the commission's official functions shall be exempt from disclosure pursuant to RSA 91-A and shall be privileged and exempt from use or disclosure in any criminal or civil matter or administrative proceeding. No person who participates in the official functions of the commission shall be compelled to testify or produce evidence in any judicial or administrative proceeding with respect to any matter involving exercise of his or her official duties.

Copy link
(c)

Commission members, their agents and employees, shall not be subject to, and shall be immune from, claims, suits, liability, damages or any other recourse, civil or criminal, arising from any act, proceeding, decision or determination undertaken or performed or recommendation made, provided such persons acted in good faith and without malice in carrying out their responsibilities, authority, duties, powers and privileges of the offices conferred by this subdivision upon them.

Copy link
(d)

No organization, institution, or person furnishing information, data, reports, or records to the commission shall be liable in damages to any person or subject to any other recourse, civil or criminal.

Copy link
(e)

Any person who knowingly discloses case records or other information obtained from commission proceedings shall be guilty of a misdemeanor. Source. 2020, 39:54, eff. Sept. 27, 2020. 2025, 141:292, eff. July 1, 2025.

Copy link

Source note

Source. 2020, 39:54, eff. Sept. 27, 2020. 2025, 141:292, eff. July 1, 2025.

Source history

  • 2020, 39:54, eff. Sept. 27, 2020
  • 2025, 141:292, eff. July 1, 2025

Related materials

Bill relationships

  • 2025 HB2 amend

    tion, treatment, and recovery] the governor's commission on addiction, treatment, and prevention in accordance with RSA 12-J:1. 141:292 New Hampshire Drug Overdose Fatality Review Commission; Commission. Amend RSA 126-DD:1, I(g) to read as follows: (g) The chairperson of the governor's commission on [alcohol and drug abuse prevention,] addiction, treatment, and [recovery] prevention, or designee. 141:293 New Hampshire Opioid Aba